StockCall Pre-Market Review on Anthera Pharma, Impax Laboratories, Star Scientific, and Cubist Pharma

LONDON, March 18, 2013 /PRNewswire/ --

Markets broke their upward streak on the last trading session of the previous week. The bullish sentiments, however, still persists as the major indices are at an all time high. In the coming week, the stocks are expected to show the impact of ongoing budget negotiations. Wall Street expects the bull's run to continue for the foreseeable future. Our research team took a look at the Healthcare sector, more precisely the drug makers industry which includes major companies like Anthera Pharmaceuticals (NASDAQ: ANTH), Impax Laboratories Inc. (NASDAQ: IPXL), Star Scientific Inc. (NASDAQ: STSI) and Cubist Pharmaceuticals Inc. (NASDAQ: CBST).  StockCall analysts initiated preliminary technical research on ANTH, IPXL, STSI, and CBST. These free reports are accessible by signing today at

http://www.stockcall.com/register

Anthera Pharmaceuticals Inc. shares fell in Friday's trading session, ending the day 1.23 percent lower at $0.642. The stock fell to an intra-day low of $0.64, while its intra-day high stood at $0.67. Despite the downward move, the company has gained more than 3 percent this year, compared to a gain of 11.29 percent for the S&P 500. The drug maker's shares have strong support at around $0.60, as the stock shows a neutral trend. Its first resistance level is at $0.66. The stock has declined 79.75 percent over the course of past 52 weeks and it oscillated between $0.49 and $3.25 during the same time period. The free technical analysis on ANTH is available by signing up at

http://www.StockCall.com/ANTH031813.pdf  

Impax Laboratories Inc.'s stock is in a bearish mode and is trading in-line with its 20-day moving average price of $15.77. It ended its latest trading session 2.95 percent lower at $15.77. The stock oscillated in the range of $15.54 and $16.37 during Friday's session. It trades at Price/Earnings ratio of 19.23, slightly higher than its peer companies, making it an expensive stock to own. The company is expected to face its first resistance level at $16.89 while its first support level is at $14.63. Upon breaching this level, the stock may fall down to $14.05 levels. Register now to download the free research on IPXL at

http://www.StockCall.com/IPXL031813.pdf  

Star Scientific Inc. traded in the range of $1.96 and $2.06 during Friday's session. It opened at $2.04 and closed at $19.8, down 2.46 percent. The stock is currently in a bearish mode and has its first resistance level at $2.13. Upon breaching this level, the company may go as high as $2.62. It traded 1.17 million shares and is below its 20-day moving average price, confirming a bearish trend. Its first support level is at $1.96. So far in 2013, the stock is down 25.28 percent. Free report on STSI can be accessed by registering at

http://www.StockCall.com/STSI031813.pdf  

Despite a sharp downward move in its previous trading session, Cubist Pharmaceuticals Inc. is still up 11.92 percent for the year. It has up 6.28 percent in the past 52 weeks. The stock closed Friday's session 1.92 percent lower at $46.56 on volume of 854,713 shares. Its average trading volume stands at 748,185 shares. The company shares currently face resistance at around $47.98. The stock has support at around $46.05. It is currently trading above its 20-day and 50-day moving averages. Register with StockCall and download the research on CBST for free at

http://www.StockCall.com/CBST031813.pdf  

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com  

SOURCE StockCall.com